Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.

about

Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.The use of bisphosphonates in women: when to use and when to stop.

P2860

Q38192058-94CE5954-6546-4E9A-8AF8-CE55B3E4D130 Q38584336-FCC761EE-4625-4C2D-BFAF-C142E55A17EF

P2860

Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.

Item

http://www.wikidata.org/entity/Q38102040

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.

@en

type

Item

label

Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.

@en

prefLabel

Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.

@en

P1476

Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis

@en

P2093

Ignazio Sblendorio

http://www.w3.org/2001/XMLSchema#string

Stefano Lello

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

The effects of bazedoxifene on mammographic breast density in postmenopausal women with osteoporosis.

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis.

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.

The search for the ideal SERM.

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.

P304

883-892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2013.794221

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Rossini

davide gatti

P577

2013-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23621618

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.

about

P2860

P2860

Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921